Breast Cancer
Intensified Chemotherapy/Stem Cell Treatment May Not Improve Survival
Published in Blood Weekly, March 29th, 2001
Although many researchers suspect that early dose intensification should produce better results than late intensification, the reports from "randomized trials comparing standard- and high-dose chemotherapy with ASCT [autologous stem cell transplantation] are still controversial," according to Andreas Schneeweiss and colleagues.
Despite improving initial complete remission (CR) rates, Schneeweiss et al. found that double- and triple-dose HDCT (D- and T-HDCT) had no significant...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2001-03-29)
More Articles from Blood Weekly
- Chronic Myeloid Leukemia
Quantitative Polymerase Chain Reaction Tests Can Predict Transplant Outcome - Stem Cell Transplantation
Stromal Cell Co-Administration Enhances Hemopoietic Colony Formation - Dialysis
Hemodialyzer Reuse Not Linked To Increased Mortality Risk - Non-Hodgkin's Lymphoma
NAEPP Protocol Is Effective For Relapsed Elderly Patients - Severe Aplastic Anemia
Stem Cell Transplantation Is Effective For High-Risk Patient Treatment - Anticoagulation
Synthetic Factor Xa Inhibitor Can Maximize Benefit Of Coronary Fibrinolysis - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
